Learn more

REATA PHARMACEUTICALS INC

Overview
  • Total Patents
    432
  • GoodIP Patent Rank
    9,315
  • Filing trend
    ⇩ 71.0%
About

REATA PHARMACEUTICALS INC has a total of 432 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and machines are STERIX LTD, PFIZER PRODUCTS INC SA ORGANIZ and SANOFI SYNTHELABO.

Patent filings per year

Chart showing REATA PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Jiang Xin 222
#2 Visnick Melean 209
#3 Anderson Eric 146
#4 Meyer Colin J 86
#5 Bender Christopher F 84
#6 Liu Xiaofeng 84
#7 Lee Chitase 67
#8 Kral Robert M 48
#9 Bolton Gary 44
#10 Caprathe Bradley 39

Latest patents

Publication Filing date Title
US2021040142A1 C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
WO2019246461A1 Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
CA3103726A1 Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma
AU2019271126A1 Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
SG11202007530XA Co-crystal forms of a novobiocin analog and proline
TW201835051A Pyrimidine tricyclic enone derivatives for inhibition of ROR[gamma] and other uses
WO2018089539A1 Methods of treating alport syndrome using bardoxolone methyl or analogs thereof
AU2016326704A1 C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses
CN107428698A Imidazole radicals tricyclene ketone as anti-oxidant inflammation modulators
AU2015200516A1 Novel forms of CDDO methyl ester
CN107074801A Aryl and the pyrazolyl and pyrimidine radicals tricyclene ketone of aryl alkyl substitution are used as anti-oxidant inflammation modulators
US2015152071A1 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
AU2014308600A1 Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
AU2014208299A1 Method of treating obesity using antioxidant inflammation modulators
WO2014040073A1 C13-hydroxy derivatives of oleanolic acid and methods of use thereof
WO2014040060A1 C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
HUE036797T2 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US2015148384A1 A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
TW201348245A 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
AU2012229244A1 C4-monomethyl triterpenoid derivatives and methods of use thereof